| abstract |
This invention relates to a series of substituted benzophenone and sulfone compounds of the formula (I) that exhibit acitivity as glycine transport inhibitors, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans. |